Cargando…

Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients

BACKGROUND: Chronic hepatitis B virus (HBV) infection is a leading cause of liver morbidity and mortality worldwide. Liver fibrosis resulting from viral infection-associated inflammation and direct liver damage plays an important role in disease management and prognostication. The mechanisms underly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Qun-Yan, Feng, Ya-Dong, Han, Pei, Yang, Feng, Song, Guang-Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385564/ https://www.ncbi.nlm.nih.gov/pubmed/32774066 http://dx.doi.org/10.3748/wjg.v26.i27.3917

Ejemplares similares

Immune response pattern varies with the natural history of chronic hepatitis B
por: Wang, Wen-Tao, et al.
Publicado: (2019)

Conservation and variability of hepatitis B core at different chronic hepatitis stages
por: Yll, Marçal, et al.
Publicado: (2020)

Enhanced hepatic differentiation in the subpopulation of human amniotic stem cells under 3D multicellular microenvironment
por: Furuya, Kinji, et al.
Publicado: (2019)

Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma
por: Chen, Qi-Feng, et al.
Publicado: (2019)

Association between polymorphisms of the APOBEC3G gene and chronic hepatitis B viral infection and hepatitis B virus-related hepatocellular carcinoma
por: He, Xiu-Ting, et al.
Publicado: (2017)

Potential microRNA panel for the diagnosis and prediction of overall survival of hepatocellular carcinoma with hepatitis B virus infection
por: Zhang, Qi, et al.
Publicado: (2020)

Morin enhances hepatic Nrf2 expression in a liver fibrosis rat model
por: Sang, Liang, et al.
Publicado: (2017)

Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway
por: Zhang, Yan-Zhen, et al.
Publicado: (2019)

Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice
por: Fan, Jing, et al.
Publicado: (2019)

Identification of hepatitis B virus and liver cancer bridge molecules based on functional module network
por: Huang, Xiao-Bing, et al.
Publicado: (2019)

Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis
por: Bennett, Robert G, et al.
Publicado: (2017)

Construction of a replication-competent hepatitis B virus vector carrying secreted luciferase transgene and establishment of new hepatitis B virus replication and expression cell lines
por: Ruan, Jie, et al.
Publicado: (2019)

Mechanism of combined use of vitamin D and puerarin in anti-hepatic fibrosis by regulating the Wnt/β-catenin signalling pathway
por: Huang, Gan-Rong, et al.
Publicado: (2018)

Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C
por: Schaefer, Esperance A K, et al.
Publicado: (2016)

Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease
por: Amin, Kawa, et al.
Publicado: (2017)

On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B
por: Chang, Xiu-Juan, et al.
Publicado: (2019)

Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets
por: Huang, Zi-Lin, et al.
Publicado: (2019)

VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors
por: Wang, Mu-Qi, et al.
Publicado: (2022)

Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells
por: Han, Qiu-Ju, et al.
Publicado: (2021)

Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B
por: Wang, Xuyang, et al.
Publicado: (2017)

Characterization of hepatitis B virus X gene quasispecies complexity in mono-infection and hepatitis delta virus superinfection
por: Godoy, Cristina, et al.
Publicado: (2019)

Mesenchymal stem cells rescue acute hepatic failure by polarizing M2 macrophages
por: Li, Yan-Wei, et al.
Publicado: (2017)

miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma
por: Wu, Hong-Jie, et al.
Publicado: (2017)

Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir
por: Wang, Xiao-Xiao, et al.
Publicado: (2018)

Immunological classification of hepatitis B virus-positive hepatocellular carcinoma by transcriptome analysis
por: Li, Sheng-Wei, et al.
Publicado: (2022)

MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2
por: Wu, Jun-Cheng, et al.
Publicado: (2019)

Angiotensin-converting enzyme 2 improves liver fibrosis in mice by regulating autophagy of hepatic stellate cells
por: Wu, Ying, et al.
Publicado: (2023)

Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis
por: Iyer, Janaki K, et al.
Publicado: (2017)

Primary animal experiment to test the feasibility of a novel Y-Z magnetic hepatic portal blocking band
por: Zhang, Miao-Miao, et al.
Publicado: (2023)

Protective effects of Foeniculum vulgare root bark extract against carbon tetrachloride-induced hepatic fibrosis in mice
por: Zhang, Cai, et al.
Publicado: (2017)

Different pre-S deletion patterns and their association with hepatitis B virus genotypes
por: Chen, Bing-Fang
Publicado: (2016)

Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation
por: Wei, Zhi-Qiang, et al.
Publicado: (2017)

Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B
por: Hu, Yan-Chao, et al.
Publicado: (2017)

RNA interference targeting the platelet-derived growth factor receptor β subunit ameliorates experimental hepatic fibrosis in rats
por: Chen, Si-Wen, et al.
Publicado: (2008)

Proton pump inhibitors increase the severity of hepatic encephalopathy in cirrhotic patients
por: Fasullo, Matthew, et al.
Publicado: (2019)

Everolimus halts hepatic cystogenesis in a rodent model of polycystic-liver-disease
por: Temmerman, Frederik, et al.
Publicado: (2017)

Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF β1/Smad3 and NF-κB signaling pathways
por: Shi, Liu, et al.
Publicado: (2023)

Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis via regulation of TGF-β/Smad signaling pathway
por: Zou, Gao-Liang, et al.
Publicado: (2019)

Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C
por: Hernández-Bartolomé, Ángel, et al.
Publicado: (2016)

Hepatitis B virus upregulates host expression of α-1,2-mannosidases via the PPARα pathway
por: Hu, Song, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ieebmf813iqi8ug3agb485rmru